Jordi Riba
Pioneer Researcher in Ayahuasca Pharmacology (1968-2020)
Data updated
Research Footprint
Jordi Riba appears in 34 tracked papers (2001–2022), most studied alongside Ayahuasca, DMT and Psilocybin, across Depressive Disorders, Neuroimaging & Brain Measures and Healthy Volunteers.
Most-cited paper: Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial (814 citations).
Frequent co-authors: Maria Barbanoj, Draulio Araújo and Marta Valle.
Publication Landscape
How the 34 papers Blossom tracks for Jordi Riba line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.
How has Jordi Riba's publishing grown?
SourcedTracked papers by publication year; 7 earlier papers published before 2008. Click a year for the running total.
Don't read as total output: only the 34 of 34 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.
What does Jordi Riba publish on?
SourcedTracked papers per topic. Orange marks the largest research focus.
Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Where does Jordi Riba publish?
SourcedTracked papers per journal. Orange marks the most-used journal.
Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Background & Research
Jordi Riba was a visionary pharmacologist who led the first scientific investigations into ayahuasca in human volunteers. His seminal work at the Universitat Autònoma de Barcelona and Maastricht University demonstrated the safety and pharmacokinetics of orally active DMT and utilized neuroimaging to map the brain's response to the 'Amazonian brew.' His research laid the foundation for modern clinical science on ayahuasca.
Key Impact
Conducted the first placebo-controlled trials with ayahuasca, establishing its safety and neurophysiological impact.
Collaboration Network
46 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Jordi Riba's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.
Affiliations
Institutions, companies, and organisations Jordi Riba is associated with.